Ascentawits Pharmaceuticals Ltd. is a Chinese company located in Shenzhen. The firm engages in research and development of anti-tumor, small molecular and cancer drugs. It was founded in 2014 by Jian Xin Duan. Yanbin Xie and Jian Xin Duan are the current co-CEOs of the firm.

Zhejiang Plaatu Pharmaceutical Technology Co., Ltd., established on 2010-08-20, Business scope includes medical technology,Biotechnology R&D,technical consulting,Achievement transfer;R&D and technology transfer services of fluorine chemicals;Chemical raw materials and products(Free of hazardous chemicals and precursor chemicals)Sales.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Yunnan Precious Metals Laboratory Co., Ltd., established on 2021-10-26, Business scope includes general items:New material technology research and development;New material technology promotion service;Resource recycling technology research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Non-ferrous metal rolling processing;Manufacturing of non-ferrous metal alloys;Non-ferrous metal alloy sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Sichuan Yingrui Pharmaceutical Technology Co., Ltd., established on 2018-08-09, Business scope includes licensed projects:Class III medical device business;Drug retail;Drug Wholesale.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Engineering and Technology Research and Experimental Development.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

BioSight is a biopharmaceutical private company founded in 2000 and re launched in mid 2009, revolutionizing the research and development of innovative cancer targeted pro-drugs. BioSight has developed technology S2DOT TM and a pipeline of targeted pro-drugs, that can target and release chemotherapy drugs inside cancer cells, while significantly minimizing the systemic toxicity associated with conventional chemotherapy ​​treatments.​​​